abiprubart (KPL-404) / Kiniksa  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
abiprubart (KPL-404) / Kiniksa
NCT04497662: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of KPL-404 in Healthy Subjects

Completed
1
52
US, RoW
KPL-404, Matching Placebo
Kiniksa Pharmaceuticals, Ltd.
Healthy Volunteers
01/21
03/21

Download Options